Health ❯ Healthcare ❯ Pharmaceuticals ❯ Medications

GLP-1 Receptor Agonists

WHO Backs Long-Term GLP-1 Use for Obesity in First Global Guideline

WHO’s conditional endorsement comes with a warning of severe access shortfalls by 2030.

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Costco to Offer Ozempic and Wegovy for $499 a Month to Self-Pay Members Nationwide

Australian Study Finds Contraception Gaps and Pregnancies After GLP-1 Weight-Loss Prescriptions

Lilly’s Orforglipron Pill Hits Phase 3 Goals, Clearing Path to Global Filings

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy